NCT06108479 2026-03-18Study of DF6215 in Patients With Advanced Solid TumorsDragonfly TherapeuticsPhase 1 Completed35 enrolled
NCT03142334 2026-03-10KEYNOTE-564Merck Sharp & Dohme LLCPhase 3 Completed994 enrolled 10 charts 1 FDA
NCT05858749 2026-02-27A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).PfizerCompleted494 enrolled